TCH GROUP, LLC for AMGEN USA INC
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 21, 2008 | $40,000 | Replaced |
| 2nd Quarter - Amendment | Jul 22, 2008 | $40,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S. 1145, HR 1908-Patent Reform Act of 2007. Specifically, issues related to intellectual property and process patents.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Medicare/Medicaid MMM
S.J. Resolution 305, Sense of the Senate regarding Medicare's National Coverage Determination of Erythropoieses-Stimulating-Agents (ESAs); S.J. Resolution 22, providing for Congressional Disapproval of a National Coverage Decision restricting Medicare Coverage of Erythropoeisis-Stimulating Agents (ESAs); S. 1983, The Children's Health Insurance Program Reauthorization Act of 2007; S. 2499, Medicare, Medicaid, and SCHIP Extension Act of 2007. S.3101, H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN HOLSCLAW | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.